Comparison Overview
MACLEODS PHARMACEUTICALS LTD.
MACLEODS PHARMACEUTICALS LTD.
304, Atlanta Arcade Marol Church Road, Mumbai, 400059, IN
Last Update: 30/03/2026
A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermato...
Sanofi
46 Avenue de la Grande-Armée, Paris, France, FR, 75017
Last Update: 20/05/2026
We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world,...
Compliance Ranges Comparison
MACLEODS PHARMACEUTICALS LTD.
Sanofi
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Sanofi in 2026.
Incident History - MACLEODS PHARMACEUTICALS LTD. (X = Date, Y = Severity)
MACLEODS PHARMACEUTICALS LTD. cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Sanofi (X = Date, Y = Severity)
Sanofi cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
MACLEODS PHARMACEUTICALS LTD.
Sanofi
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.